Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists.

Verdalles U, Goicoechea M, García de Vinuesa S, Torres E, Hernández A, Verde E, Pérez de José A, Luño J.

Nefrologia. 2019 Aug 23. pii: S0211-6995(19)30122-5. doi: 10.1016/j.nefro.2019.04.012. [Epub ahead of print] English, Spanish.

2.

Factors associated with moderate neonatal hyperthyrotropinemia.

Cortés-Castell E, Juste M, Palazón-Bru A, Goicoechea M, Gil-Guillén VF, Rizo-Baeza MM.

PLoS One. 2019 Jul 18;14(7):e0220040. doi: 10.1371/journal.pone.0220040. eCollection 2019.

3.

IgA Nephropathy in Elderly Patients.

Sevillano AM, Diaz M, Caravaca-Fontán F, Barrios C, Bernis C, Cabrera J, Calviño J, Castillo L, Cobelo C, Delgado-Mallén P, Espinosa M, Fernandez-Juarez G, Fernandez-Reyes MJ, Garcia-Osuna R, Garcia P, Goicoechea M, Gonzalez-Cabrera F, Guzmán DA, Heras M, Martín-Reyes G, Martinez A, Olea T, Peña JK, Quintana LF, Rabasco C, López Revuelta K, Rodas L, Rodriguez-Mendiola N, Rodriguez E, San Miguel L, Sanchez de la Nieta MD, Shabaka A, Sierra M, Valera A, Velo M, Verde E, Ballarin J, Noboa O, Moreno JA, Gutiérrez E, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1183-1192. doi: 10.2215/CJN.13251118. Epub 2019 Jul 16.

PMID:
31311818
4.

Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.

Barbieri D, Goicoechea M, Sánchez-Niño MD, Ortiz A, Verde E, Verdalles U, Pérez de José A, Delgado A, Hurtado E, Sánchez-Cámara L, Lopez-Lazareno N, García-Prieto A, Luño J.

Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.

5.

Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals.

Barbieri D, García-Prieto A, Torres E, Verde E, Goicoechea M, Luño J.

Clin Kidney J. 2018 Jul 9;12(3):362-364. doi: 10.1093/ckj/sfy055. eCollection 2019 Jun.

6.

Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial.

de Morales AM, Goicoechea M, Verde E, Carbayo J, Barbieri D, Delgado A, Verdalles U, de Jose AP, Luño J.

J Nephrol. 2019 Aug;32(4):581-587. doi: 10.1007/s40620-019-00607-0. Epub 2019 Apr 4.

PMID:
30949987
7.

Isolation and characterization of myogenic precursor cells from human cremaster muscle.

Naldaiz-Gastesi N, Goicoechea M, Aragón IM, Pérez-López V, Fuertes-Alvarez S, Herrera-Imbroda B, López de Munain A, de Luna-Diaz R, Baptista PM, Fernández MA, Lara MF, Izeta A.

Sci Rep. 2019 Mar 5;9(1):3454. doi: 10.1038/s41598-019-40042-6.

8.

No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients: A Real-world Experience.

Box MJ, Ortwine KN, Goicoechea M; Scripps Antimicrobial Stewardship Program (SASP).

Open Forum Infect Dis. 2018 Dec 13;5(12):ofy192. doi: 10.1093/ofid/ofy192. eCollection 2018 Dec.

9.

Atypical haemolytic uremic syndrome: when multiple etiologies meet.

Barbieri D, García-Prieto A, Verde E, Goicoechea M, Luño J.

Int Urol Nephrol. 2018 Nov;50(11):2109-2110. doi: 10.1007/s11255-018-1980-0. Epub 2018 Sep 24. No abstract available.

PMID:
30251008
10.

Impact of the application of the JNC 8 and KDIGO-2013 guidelines on hypertension and lipid control in a Nephrology outpatient clinic.

Galán I, Verdalles Ú, García de Vinuesa M, Quiroga B, Goicoechea M, Pérez A, Verde E, Luño J.

Nefrologia. 2018 Jul - Aug;38(4):379-385. doi: 10.1016/j.nefro.2017.10.003. English, Spanish.

11.

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).

Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J.

Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1.

PMID:
29943364
12.

Impact of anticoagulation and platelet antiaggregation on anaemia and haemorragic events in patients with chronic kidney disease stages 3 and 4.

García-Prieto A, Goicoechea M, Linares T, Panizo N, García de Vinuesa MS, Verdalles Ú, Verde E, Pérez de José A, Luño J.

Med Clin (Barc). 2018 Dec 21;151(12):476-480. doi: 10.1016/j.medcli.2018.01.021. Epub 2018 Mar 2. English, Spanish.

PMID:
29503026
13.

Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.

Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J.

Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24.

PMID:
28987723
14.

Lesinurad: what the nephrologist should know.

Sanchez-Niño MD, Zheng-Lin B, Valiño-Rivas L, Sanz AB, Ramos AM, Luño J, Goicoechea M, Ortiz A.

Clin Kidney J. 2017 Oct;10(5):679-687. doi: 10.1093/ckj/sfx036. Epub 2017 May 26.

15.

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass.

Galán I, Goicoechea M, Quiroga B, Macías N, Santos A, García de Vinuesa MS, Verdalles Ú, Cedeño S, Verde E, Pérez de José A, García A, Luño J.

Nefrologia. 2018 Jan - Feb;38(1):73-78. doi: 10.1016/j.nefro.2017.04.006. Epub 2017 Aug 30. English, Spanish.

16.

Hypokalemia due to excessive cola consumption.

García-Prieto A, Verde E, Goicoechea M.

Med Clin (Barc). 2017 Dec 20;149(12):555-556. doi: 10.1016/j.medcli.2017.06.014. Epub 2017 Jul 21. English, Spanish. No abstract available.

PMID:
28736066
17.

Cardiovascular risk prediction in chronic kidney disease patients.

Cedeño Mora S, Goicoechea M, Torres E, Verdalles Ú, Pérez de José A, Verde E, García de Vinuesa S, Luño J.

Nefrologia. 2017 May - Jun;37(3):293-300. doi: 10.1016/j.nefro.2016.10.002. Epub 2017 May 8. English, Spanish.

18.

Changes in the clinical presentation of immunoglobulin A nephropathy: data from the Spanish Registry of Glomerulonephritis.

Gutiérrez E, Praga M, Rivera F, Sevillano A, Yuste C, Goicoechea M, López-Gómez JM; all members of the Spanish Registry of Glomerulonephritis.

Nephrol Dial Transplant. 2018 Mar 1;33(3):472-477. doi: 10.1093/ndt/gfx058.

PMID:
28460086
19.

Impact of prematurity and immigration on neonatal screening for sickle cell disease.

Cortés-Castell E, Palazón-Bru A, Pla C, Goicoechea M, Rizo-Baeza MM, Juste M, Gil-Guillén VF.

PLoS One. 2017 Feb 7;12(2):e0171604. doi: 10.1371/journal.pone.0171604. eCollection 2017.

20.

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen.

Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team.

HIV Clin Trials. 2017 Mar;18(2):67-74. doi: 10.1080/15284336.2017.1282578. Epub 2017 Jan 30.

21.

Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M, García-Prieto A, Torres E, Reque J, Luño J.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217. Epub 2016 Oct 3.

22.

Identification and Characterization of the Dermal Panniculus Carnosus Muscle Stem Cells.

Naldaiz-Gastesi N, Goicoechea M, Alonso-Martín S, Aiastui A, López-Mayorga M, García-Belda P, Lacalle J, San José C, Araúzo-Bravo MJ, Trouilh L, Anton-Leberre V, Herrero D, Matheu A, Bernad A, García-Verdugo JM, Carvajal JJ, Relaix F, Lopez de Munain A, García-Parra P, Izeta A.

Stem Cell Reports. 2016 Sep 13;7(3):411-424. doi: 10.1016/j.stemcr.2016.08.002. Epub 2016 Sep 1.

23.

Prevalence and characteristics of patients with resistant hypertension and chronic kidney disease.

Verdalles Ú, Goicoechea M, Garcia de Vinuesa S, Quiroga B, Galan I, Verde E, Perez de Jose A, Luño J.

Nefrologia. 2016 Sep - Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18. English, Spanish.

24.

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e48-50. doi: 10.1097/QAI.0000000000000990. No abstract available.

25.

The effect of some medications given to CKD patients on vitamin D levels.

Yuste C, Quiroga B, de Vinuesa SG, Goicoechea MA, Barraca D, Verdalles U, Luño J.

Nefrologia. 2015;35(2):150-6. doi: 10.1016/j.nefro.2015.05.016. Epub 2015 Jun 23.

26.

Muscle wasting in myotonic dystrophies: a model of premature aging.

Mateos-Aierdi AJ, Goicoechea M, Aiastui A, Fernández-Torrón R, Garcia-Puga M, Matheu A, López de Munain A.

Front Aging Neurosci. 2015 Jul 9;7:125. doi: 10.3389/fnagi.2015.00125. eCollection 2015. Review.

27.

Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?

Verdalles U, García de Vinuesa S, Goicoechea M, Macías N, Santos A, Perez de Jose A, Verde E, Yuste C, Luño J.

Nephrology (Carlton). 2015 Aug;20(8):567-71. doi: 10.1111/nep.12475.

PMID:
25818266
28.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.

Quiroga B, Galán I, García de Vinuesa S, Goicoechea M, Verdalles Ú, Luño J.

Nephrol Dial Transplant. 2015 May;30(5):801-6. doi: 10.1093/ndt/gfv059. Epub 2015 Mar 9.

PMID:
25753805
29.

Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.

Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.

Am J Kidney Dis. 2015 Apr;65(4):543-9. doi: 10.1053/j.ajkd.2014.11.016. Epub 2015 Jan 13.

PMID:
25595565
30.

Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.

Caro J, Gutiérrez-Solís E, Rojas-Rivera J, Agraz I, Ramos N, Rabasco C, Espinosa M, Valera A, Martín M, Frutos MÁ, Perea L, Juárez GF, Ocaña J, Arroyo D, Goicoechea M, Fernández L, Oliet A, Hernández Y, Romera A, Segarra A, Praga M; Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).

Nephrol Dial Transplant. 2015 Mar;30(3):467-74. doi: 10.1093/ndt/gfu306. Epub 2014 Oct 1.

PMID:
25274748
31.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, Oliveras A, Portolés J, Rubio E, Segura J, Aranda P, de Francisco AL, Del Pino MD, Fernández-Vega F, Górriz JL, Luño J, Marín R, Martínez I, Martínez-Castelao A, Orte LM, Quereda C, Rodríguez-Pérez JC, Rodríguez M, Ruilope LM.

Nefrologia. 2014 May 21;34(3):302-16. doi: 10.3265/Nefrologia.pre2014.Feb.12464. Epub 2014 Mar 6. English, Spanish.

32.

Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.

Beliakova-Bethell N, Jain S, Woelk CH, Witt MD, Sun X, Lada SM, Spina CA, Goicoechea M, Rought SE, Haubrich R, Dubé MP.

Antiviral Res. 2014 Jul;107:42-9. doi: 10.1016/j.antiviral.2014.04.005. Epub 2014 Apr 24.

33.

Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease.

Vega A, García de Vinuesa S, Goicoechea M, Verdalles U, Martínez-Pueyo ML, Chacón A, Quiroga B, Luño J.

Int Urol Nephrol. 2014 Jun;46(6):1161-7. doi: 10.1007/s11255-013-0607-8. Epub 2013 Nov 22.

PMID:
24265040
34.

Urate reduction and renal preservation: what is the evidence?

Macías N, Goicoechea M, de Vinuesa MS, Verdalles U, Luño J.

Curr Rheumatol Rep. 2013 Dec;15(12):386. doi: 10.1007/s11926-013-0386-3. Review.

PMID:
24203097
35.

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.

36.

Cardiovascular events and mortality in chronic kidney disease (stages I-IV).

Quiroga B, Verdalles Ú, Reque J, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(4):539-45. doi: 10.3265/Nefrologia.pre2013.May.11895. English, Spanish.

37.

In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.

Blázquez L, Aiastui A, Goicoechea M, Martins de Araujo M, Avril A, Beley C, García L, Valcárcel J, Fortes P, López de Munain A.

Hum Mutat. 2013 Oct;34(10):1387-95. doi: 10.1002/humu.22379. Epub 2013 Aug 7.

PMID:
23864287
38.

Idiopathic fibrosis as the cause of obstructive uropathy.

Santos A, Quiroga B, Macías N, Goicoechea M, García-de Vinuesa S.

Nefrologia. 2013;33(3):439-40. doi: 10.3265/Nefrologia.pre2012.Sep.11705. English, Spanish. No abstract available.

39.

Hyporeninaemic hypoaldosteronism associated with membranous nephropathy: new hypotheses with regard to sodium retention in patients with proteinuria.

Quiroga B, García de Vinuesa S, Goicoechea M, Luño J.

Nefrologia. 2013;33(3):428-9. doi: 10.3265/Nefrologia.pre2013.Mar.11841. English, Spanish. No abstract available.

40.

Murine muscle engineered from dermal precursors: an in vitro model for skeletal muscle generation, degeneration, and fatty infiltration.

García-Parra P, Naldaiz-Gastesi N, Maroto M, Padín JF, Goicoechea M, Aiastui A, Fernández-Morales JC, García-Belda P, Lacalle J, Álava JI, García-Verdugo JM, García AG, Izeta A, López de Munain A.

Tissue Eng Part C Methods. 2014 Jan;20(1):28-41. doi: 10.1089/ten.TEC.2013.0146. Epub 2013 Jun 22.

41.

Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD).

Verdalles U, de Vinuesa SG, Goicoechea M, Quiroga B, Reque J, Panizo N, Arroyo D, Luño J.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv31-5. doi: 10.1093/ndt/gfs420.

PMID:
23258808
42.

[Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease].

Yuste C, García De Vinuesa S, Goicoechea M, Barraca D, Panizo N, Quiroga B, Luño J.

Med Clin (Barc). 2013 Oct 19;141(8):338-42. doi: 10.1016/j.medcli.2012.07.026. Epub 2012 Nov 23. Spanish.

PMID:
23182534
43.

Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis.

Quiroga B, Verde E, Abad S, Vega A, Goicoechea M, Reque J, López-Gómez JM, Luño J.

J Surg Res. 2013 Mar;180(1):51-5. doi: 10.1016/j.jss.2012.10.008. Epub 2012 Oct 29.

PMID:
23122519
44.

Hypercalcemia as a side effect of potassium binding agents.

Arroyo D, Panizo N, García de Vinuesa S, Goicoechea M, Verdalles U, Luño J.

Nefrologia. 2012;32(5):655-8. doi: 10.3265/Nefrologia.pre2012.Jun.11500. English, Spanish.

45.

Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.

Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M; Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).

J Am Soc Nephrol. 2012 Oct;23(10):1753-60. Epub 2012 Sep 6.

46.

Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.

Fernandez Juarez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Cachofeiro V, Nieto J, Fernández Vega F, Tato A, Gutierrez E; PRONEDI Study Group.

Am J Kidney Dis. 2013 Feb;61(2):211-8. doi: 10.1053/j.ajkd.2012.07.011. Epub 2012 Aug 29.

PMID:
22939518
47.

Increased prevalence of acute tubulointerstitial nephritis.

Goicoechea M, Rivera F, López-Gómez JM; Spanish Registry of Glomerulonephritis.

Nephrol Dial Transplant. 2013 Jan;28(1):112-5. doi: 10.1093/ndt/gfs143. Epub 2012 Jul 2.

PMID:
22759386
48.

Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.

Goicoechea M, Quiroga B, García de Vinuesa S, Verdalles U, Reque J, Panizo N, Arroyo D, Santos A, Macías N, Luño J.

Ren Fail. 2012;34(8):1002-9. doi: 10.3109/0886022X.2012.696469. Epub 2012 Jun 29.

PMID:
22746155
49.

Renal infarction in patient with long-standing ventricular aneurysm.

Quiroga B, Santos A, Verdalles U, Reque J, García de Vinuesa S, Goicoechea M, Pérez de José A, Macías N, Luño J.

Nefrologia. 2012;32(2):233-4. doi: 10.3265/Nefrologia.pre2012.Feb.11377. English, Spanish. No abstract available.

50.

Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.

Panizo N, Goicoechea M, García de Vinuesa S, Arroyo D, Yuste C, Rincón A, Verdalles U, Ruiz-Caro C, Quiroga B, Luño J.

Nefrologia. 2012;32(2):197-205. doi: 10.3265/Nefrologia.pre2011.Dec.11177. Epub 2012 Jan 27. English, Spanish.

Supplemental Content

Loading ...
Support Center